Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 26 Genitourinary 12 Other hematologic neoplasm 6 Breast 6 Gynecologic 5 Thoracic 2 Plasma cell 2 Lymphoid 2 Head & Neck 2 Other 1 NET 1 Myeloid 1 Endocrine 1 CNS 1

Conditions

Neuroendocrine Tumors 531 Gastro-enteropancreatic neuroendocrine tumor 58 Carcinoid Tumor 58 Neoplasms 49 Carcinoma, Neuroendocrine 44 Pancreatic Neoplasms 36 Adenoma, Islet Cell 33 Neoplasm Metastasis 28 Pheochromocytoma 25 Colorectal Neoplasms 24 Paraganglioma 23 Stomach Neoplasms 21 Breast Neoplasms 21 Prostatic Neoplasms 20 Lung Neoplasms 20 Carcinoma, Hepatocellular 20 Sarcoma 19 Carcinoma 19 Thyroid Neoplasms 18 Gastrointestinal Neoplasms 18 Neuroblastoma 15 Cholangiocarcinoma 14 Carcinoma, Renal Cell 14 Small Cell Lung Carcinoma 13 Melanoma 13 Esophageal Neoplasms 13 Serotonin Syndrome 12 Colonic Neoplasms 12 Brain Neoplasms 11 Adenocarcinoma 11

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Frailty × NET × Clear all

NCT05554003 2024-11-18

MeTe

European Institute of Oncology

Phase 2 Recruiting

Frailty, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡